Stocks and Investing Stocks and Investing
Wed, July 25, 2012

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $150 on, Jul 25th, 2012


Published on 2024-10-25 00:06:56 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $140 to $150 on, Jul 25th, 2012.

Matthew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $139 on, Tuesday, May 1st, 2012
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $159 on, Tuesday, May 1st, 2012

Contributing Sources